NCT00002152View on ClinicalTrials.gov

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

WF10

Trial Locations (1)

37203

Nashville Health Management Foundation / Vanderbilt Univ, Nashville

All Listed Sponsors
lead

Oxo Chemie GmbH

INDUSTRY